Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

earnings

A collection of 146 Posts

Health Giants Strike Billion-Dollar Deals Amidst Regulatory Turmoil post image

Health Giants Strike Billion-Dollar Deals Amidst Regulatory Turmoil

Money laundering: ED raids multiple locations in two cases of over ₹1,000 crore post image

Money laundering: ED raids multiple locations in two cases of over ₹1,000 crore

Anlon Healthcare IPO to list on Wednesday; GMP signals muted debut, price and other details here post image

Anlon Healthcare IPO to list on Wednesday; GMP signals muted debut, price and other details here

Trump Calls On Drug Companies For Vaccine Data Amid CDC Shake-Up post image

Trump Calls On Drug Companies For Vaccine Data Amid CDC Shake-Up

India eyes Russia, Brazil, Netherlands for pharma export growth as US tariffs concerns linger post image

India eyes Russia, Brazil, Netherlands for pharma export growth as US tariffs concerns linger

The Race to Produce Generic Weight-Loss Drugs: China's Pharmaceutical Surge post image

The Race to Produce Generic Weight-Loss Drugs: China's Pharmaceutical Surge

India eyes Russia, Brazil, Netherlands for pharma export growth as US tariffs concerns linger post image

India eyes Russia, Brazil, Netherlands for pharma export growth as US tariffs concerns linger

Top life sciences companies in world set up GCCs in India: EY report post image

Top life sciences companies in world set up GCCs in India: EY report

Drugmakers Boost U.S. Manufacturing Amid Tariff Threats post image

Drugmakers Boost U.S. Manufacturing Amid Tariff Threats

Global drugmakers rush to boost US presence as tariff threat looms post image

Global drugmakers rush to boost US presence as tariff threat looms

Artelo Biosciences Affirms Strong Partnering Outlook for ART27.13 Following Positive Interim Phase 2 CAReS Results post image

Artelo Biosciences Affirms Strong Partnering Outlook for ART27.13 Following Positive Interim Phase 2 CAReS Results

Gilead starts building manufacturing hub under $32 billion planned US investments post image

Gilead starts building manufacturing hub under $32 billion planned US investments